ADHD in adults
Diagnosis and treatment of ADHD in adults.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 84, 102, 101, 142, 114.
New guidelines and consensus this year
- Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHDEur Neuropsychopharmacol2026 Nov
- The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD(✰)Eur Neuropsychopharmacol2026 Oct
All papers from the last 12 months
942 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- The relationship between product-based creativity and ADHD traits in children and the associations with later well-beingJ Exp Child Psychol2027 FebPMID 42790392
- Dose-dependent efficacy and safety of centanafadine in patients with attention-deficit/hyperactivity disorder: A systematic review of the latest evidencePCN Rep2026 DecPMID 42877260Review
- Association of smoking reduction with comorbid psychiatric symptoms including ADHD, depression, anxiety, and alcohol use disorderJ Psychiatr Res2026 DecPMID 42815346
- Beyond executive dysfunction: The precuneus as an introspective monitoring hub for driving safetyNeurosci Biobehav Rev2026 DecPMID 42753838Review
- A multidisciplinary biopsychosocial approach reveals behavioural phenotypes in idiopathic hypersomnia: a prospective single-arm studySleep Med2026 DecPMID 42715883
- Convergent functional connectivity alterations in ADHD revealed by EEG: A systematic review across methods, states and spatial scalesNeurosci Biobehav Rev2026 DecPMID 42705510Systematic reviewReview
- A systematic review of neuroimaging studies of adults aged 35 and older with clinical, symptomatic and genetic risk for attention-deficit/hyperactivity disorderDialogues Clin Neurosci2026 DecPMID 42472451Systematic review
- Changing Patterns of Recent Substance Use in Emerging Adulthood and Their Associations With Cognitive Functions and Mental HealthBiol Psychiatry Glob Open Sci2026 NovPMID 42733446
- Genetic risk of depression predicts negative evaluations in social interactionsSoc Sci Med2026 NovPMID 42702169
- Lack of beneficial effect of planned treatment interruption in adults with ADHD treated with methylphenidate - clinical evidencePsychiatry Res2026 NovPMID 42679659
More psychiatry trends
All specialties →GLP-1 drugs, addiction and mood
GLP-1 based medicines studied in alcohol and substance use, and their psychiatric effects.
AI chatbots in mental health
Chatbots and language models used for mental health support.
Key point: PDC30, a self-guided automated intervention with an AI-powered counseling chatbot, improved caregiver depression, burden, and positive gains versus waitlist at 1 month.
Digital mental health apps
Smartphone apps and digital programmes for depression and anxiety.
Key point: Smartphone-delivered lifestyle medicine reduced depressive symptoms more than waitlist control and maintained within-group improvements through 3-month follow-up in probable depression.
Loneliness and health
Loneliness and social isolation as risk factors.
Gut microbiome and mental health
Links between the gut microbiome and depression or anxiety.
Psilocybin therapy
Psilocybin-assisted therapy for depression and other conditions.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
ADHD[tiab] AND adult*[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.